PHILADELPHIA –The babies were dying – without life support, they might live just another few minutes. Their families had said goodbye, and wanted their newborns to become organ donors, in hopes of saving another tiny life. But the babies’ conditions couldn’t meet the normal standards for organ donor eligibility. What to do?
The August 14 issue of the New England Journal of Medicine explores the issue of organ donation after cardiac death through the lens of emotionally charged cases like these, which occurred at the Denver Children’s Hospital. In the journal’s Perspective Roundtable, Arthur Caplan, PhD, director of the Center for Bioethics at the University of Pennsylvania School of Medicine, weighs in on the ethical considerations of the changing assumptions about when death occurs, the importance of respecting “the dead donor rule” and how to decide which patients are suitable organ donors.
To view video of Caplan’s participation in the NEJM Perspective Roundtable on these issues, or to read a transcript of the discussion, which was moderated by physician-author Atul Gawande, visit http://content.nejm.org/cgi/content/full/359/7/669/DC1.
To schedule an interview with Caplan, please contact Holly Auer at 215-349-5659; 215-200-2313; or holly.auer@uphs.upenn.edu.
###
PENN Medicine is a $3.5 billion enterprise dedicated to the related missions of medical education, biomedical research, and excellence in patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System.
Penn's School of Medicine is currently ranked #4 in the nation in U.S.News & World Report's survey of top research-oriented medical schools; and, according to most recent data from the National Institutes of Health, received over $379 million in NIH research funds in the 2006 fiscal year. Supporting 1,400 fulltime faculty and 700 students, the School of Medicine is recognized worldwide for its superior education and training of the next generation of physician-scientists and leaders of academic medicine.
The University of Pennsylvania Health System includes three hospitals — its flagship hospital, the Hospital of the University of Pennsylvania, rated one of the nation’s top 10 “Honor Roll” hospitals by U.S.News & World Report; Pennsylvania Hospital, the nation's first hospital; and Penn Presbyterian Medical Center — a faculty practice plan; a primary-care provider network; two multispecialty satellite facilities; and home care and hospice
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.